Programmdetails

Postervorträge

Pathophysiologische Aspekte der HFpEF

Donnerstag, 4. April | 09:30 - 11:00 Uhr | Posterbereich 21

Vorsitz/Chair: Tina Stegmann (Leipzig), Martin Stockburger (Nauen)

Agenda

(P533)
Effects of Renal Denervation on Pulse Wave Properties in Patients With and Without Heart Failure With Preserved Ejection Fraction
K. Fengler (Leipzig)
(P534)
Endomyocardial biopsy-derived fibroblasts as a screening tool to distinct heart failure with reduced and preserved ejection fraction
I. Matz (Berlin)
(P535)
The Role of Left Atrial Function in the Continuum of Heart Failure with preserved Ejection Fraction
S. Rosch (Leipzig)
(P536)
Effects of semaglutide plus empagliflozin in a rat model of heart failure with preserved ejection fraction: Focus on excitation-contraction coupling and mitochondrial function
A.-N. Landthaler (Würzburg)
(P537)
Diagnose HFpEF – Diagnosestellung der Herzinsuffizienz mit erhaltener Ejektionsfraktion bei Patienten mit unklarer Belastungsdyspnoe – Validierung gegen den invasiven Goldstandard
A.-C. Hübner (Leipzig)
(P538)
Non-invasive Myocardial Work Analysis refines the understanding of left ventricular performance in heart failure with preserved ejection fraction
A.-M. Chitroceanu (Berlin)
(P539)
Left atrial roof enlargement is a distinct feature of Heart Failure with preserved Ejection Fraction
S. J. Backhaus (Göttingen)
(P540)
Prognostic impact of acute decompensated heart failure in patients with heart failure and mildly reduced ejection fraction
T. Schupp (Mannheim)
Diese Seite teilen